Global Antipsychotic Drugs Market Size,Share,Trends 2020

1
Global Antipsychotic Drugs Market (Brand,
Application and Geography) 2013-2020
www.bigmarketresearch.com
2
Report Description
Antipsychotic drugs are also termed as major
tranquilizers or neuroleptics and these are
primarily used to treat psychosis. The common
psychotic disorders, where these drugs are
majorly used include schizophrenia,
hallucinations, delusions, bipolar disorder and
others. The antipsychotic drugs market is
expected to grow due to the rising number of
Schizophrenic patients. However, patent
expiration of major brands could negatively
impact the market growth. Deep-dive analysis of
global antipsychotic drugs market focuses on
major market dynamics such as drivers, restrains
and opportunities. Competitive landscape section
profiles the key players on the basis of business
performance, strategic moves and SWOT analysis.
Profound analysis of segments would be helpful to
understand the product distribution trends in
each segment within the global antipsychotic
drugs market. Browse complete report _at_
http//www.bigmarketresearch.com/antipsychotic-dr
ugs-market
3
Report Description
High prevalence of Schizophrenia and psychotic
disorders are the prime drivers for global
antipsychotic drugs market. Increased drug abuse,
over prescription of drugs and addiction to
antipsychotic drugs are the additional factors
that drive the market growth for antipsychotic
drugs. However, patent expiry of major brands
over the past few years had negative impact on
market growth and it has been responsible to the
rising competition from generic drug
manufacturer. Serious side effects such as
tardive dyskinesia, associated with
antipsychotics also restraints the market growth.
Emerging economies are the opportunistic markets
for antipsychotics due to large pool of aging
population, which has high risk of psychosis, and
increased healthcare awareness. Feel free to
get enquire about report _at_ http//www.bigmarketr
esearch.com/report-enquiry/22965
4
Report Description
Global Antipsychotic Drugs Market by Brands The
global antipsychotic drugs market is segmented
into three categories based on brands such as
First, Second and Third generation antipsychotic
drugs. Except Halodol and lithium carbonate, all
first generation antipsychotic agents are called
as standard or typical antipsychotics, as they
act similar i.e., interference with
neurotransmitters. Second generation
antipsychotics are also known as atypical
antipsychotic agents and act as broad-spectrum
antagonists of dopamine, serotonin and
alpha-noradrenergic receptors. With development
of technology and growing competition to gain
largest market share, researchers are focusing on
first generation antipsychotics to better
understand their working mechanism. Abilify and
Seroquel are topmost marketed brands due their
high therapeutic efficacy and reduced side
effects. Global Antipsychotic Drugs Market by
Application The global antipsychotic drugs are
used to treat different brain disorders such as
Schizophrenia, Bipolar disorder, Dementia,
Unipolar Depression and Others. The drugs used in
Schizophrenia and psychotic depression are
expected to boost the growth of antipsychotic
drugs market due to increasing incidences of
these two conditions.
5
Report Description
Global Antipsychotic Drugs Market by
Geography Geographically, global antipsychotic
drugs market is segmented into North America,
Europe, Asia-Pacific and LAMEA. Antipsychotics
are the largely prescribed drugs in the North
American region due to large patient pool
suffering from mental and psychotic disorders.
Asia-Pacific and LAMEA are the lucrative market
for global antipsychotic drugs manufacturers, due
to large patient pool and rising healthcare
awareness. Competitive Landscape The key
players within global antipsychotic drugs market
include Eli Lilly, AstraZeneca, Pfizer,
Bristol-Myers Squibb, GlaxoSmithKline and Johnson
Johnson. Patent expiration of major brands such
as Zyprexa (by Eli Lilly) and Seroquel (by
AstraZeneca) has negatively impacted the total
revenue of this maket. Generic competition is
soaring due to patent expiration of six largest
antipsychotic drugs in 2012.
6
Report Description
High Level Analysis The comprehensive
analysis of global antipsychotic drugs market
provides an overview of the market and its key
concerns. Market segmentation is concentric
towards product distribution trends of each
segment that would be helpful to strategist in
deciding on the market segments. Market dynamics
covers market drivers, restrains and
opportunities, which would help to understand the
market behaviour. Porters Five Forces analysis
would be helpful in determining the market
profitability. Buyers bargaining power is high
for global antipsychotic drugs market due to
patent expiration of major brands and
availability of many generic medicines in the
marketplace. Global antipsychotic drugs market
has high threat from new entrants as major brands
have lost their patent protection in 2012.
Industrial rivalry is intense due to entry of
numerous generic competitors, which forces big
players to manipulate their drug prices according
to changing market trends. Request for the
Table of Contents _at_ http//www.bigmarketresearch.
com/antipsychotic-drugs-market
7
Report Description

• KEY BENEFITS
• This report offers the following benefits in
  particular
• Complete analysis of drivers, restrains and
  opportunities within global antipsychotic drugs
  market would assist professionals to understand
  the market behavior
• Profound assessment of geography focuses on niche
  market areas and provides forward looking
  perspective
• Porters Five Forces framework would assist
  strategist in decision making by analyzing the
  market profitability within global antipsychotic
  drugs market
• Comprehensive assessment of key leaders and their
  market strategies for global antipsychotic drugs
  market would be informative to professionals in
  the corporate sector

8
Report Description

• KEY DELIVERABLES
• The global antipsychotic drugs market is
  segmented into two major categories such as
  technology and geography.
• MARKET BY BRANDS
• First Generation Drugs (Standard / Typical
  Antipsychotic Agents)
• Thorazine (Chlorpromazine HCl)
• Serentil (Mesoridazine Besylate)
• Mellaril (Thioridazine HCl)
• Haldol (Haloperidol)
• Loxitane (Loxapine Succinate)
• Trilafon (Perphenazine)
• Navane (Thiothixene)
• Sordinol (Clopenthixol)
• Others

9
Report Description

• Second generation Drugs (Atypical Antipsychotic
  Agents)
• Zyprexa (Olanzapine)
• Geodon (Ziprasidone)
• Seroquel (Quetiapine)
• Risperdal (Risperidone)
• Clozaril (Clozapine)
• Invega (Paliperidone)
• Asendin (Amoxapine)
• Latuda (Lurasidone)
• Others
• Third generation Drugs
• Abilify (Aripiprazole)
• MARKET BY APPLICATION
• Schizophrenia
• Bipolar Disorder
• Dementia

10
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/antipsychotic-dru
gs-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
help_at_bigmarketresearch.com